hotspot -WSS

hotspot

author：knowledge 2025-10-01 04:14:04 - browse：65741

Electrocardiogram in the shape of the United States map — Adobe

The market for artificial intelligence in health care is about as transparent as a brick wall. New tools achieve impressive results in published studies. But it is often difficult to compare them head to head with similar products, or tell whether they will work on different kinds of patients.

A new company is promising to change that — if it can convince AI developers to expose their products to more rigorous testing.

Called Dandelion Health, the New York-based firm is launching a first-of-its-kind public service to evaluate AI products on independent data designed to root out weaknesses and reveal bias. The company said Wednesday its initial pilot program, to begin next month, will focus on testing algorithms that use electrocardiograms to predict heart conditions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Trump’s hydroxychloroquine hype: a risk to my treatment and to him

focus

WSS

Patients, digital health players weigh in on FTC's data privacy plan

Be careful with at

Megan Rapinoe shares emotional post following US Women's World Cup exit

Drug cartel violence flares in western Mexico after vigilante leader's killing

YouTube cracks down on misinformation on cancer treatment

Beware reading your test results before your doctor does

knowledge

hotspot

hotspot

Jerome Adams on the need for new antivirals for Covid

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Walensky prepares to leave CDC — and Congress — behind

Novo Nordisk touts Wegovy study, but still struggling with supply

The cancer drug shortage isn’t new — and neither are the solutions

Patients, digital health players weigh in on FTC's data privacy plan

Walensky prepares to leave CDC — and Congress — behind

Drug cartel violence flares in western Mexico after vigilante leader's killing

Psychedelics group wrestles with new pharma identity

AstraZeneca lung cancer study comes in below expectations

focus

Montana youths win climate lawsuit against state for promoting fossil fuels

A letter from the executive editor: The 2023 STATUS List

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Crowdfunding for unproven stem cell procedures spreads misinformation

Biden administration begins canceling student loan debt for 804,000 borrowers

Novo Nordisk touts Wegovy study, but still struggling with supply

focus

Wikipedia

focus

Wikipedia